The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 11, 2021

Filed:

Mar. 14, 2019
Applicant:

Phibro Animal Health Corporation, Teaneck, NH (US);

Inventors:

Grant Weaver, Kingsley, IA (US);

Jeffrey Alan Kula, Lincoln, NE (US);

Boh Chang Lin, Omaha, NE (US);

Karen Brown, Parksville, MO (US);

Wesley W. Johnson, Platte City, MO (US);

Michael Dennis Murphy, Atlantic, IA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); A61K 39/12 (2006.01); A61K 39/102 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); A61K 39/102 (2013.01); A61K 39/12 (2013.01); C12N 7/00 (2013.01); A61K 2039/543 (2013.01); A61K 2039/552 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55566 (2013.01); C12N 2760/16134 (2013.01);
Abstract

The majority of the mortality observed in young pigs occurs between three and five weeks post-weaning forinfections and between four and six weeks post-weaning forandinfections. Clinical disease control associated withandhas been attempted using antibiotic treatment, by controlled exposure with live organisms, and by vaccination, using either inactivated commercial or autogenous bacterins administered parenterally. A similar lack of protection in very young pigs is observed with various viruses including swine influenza virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus and rotavirus. Disclosed herein is an immunogenic composition comprising inactivated antigens and a mucosal adjuvant. The composition may be administered to subjects, such as animals, particularly piglets from pre-weaning through the nursery phase, such as from birth or from three to five days of age, to protect from these diseases.


Find Patent Forward Citations

Loading…